{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:35:24Z","timestamp":1789061724198,"version":"build-2803163510"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,26]],"date-time":"2013-07-26T00:00:00Z","timestamp":1374796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0068550","type":"journal-article","created":{"date-parts":[[2013,7,27]],"date-time":"2013-07-27T05:17:21Z","timestamp":1374902241000},"page":"e68550","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Rifaximin-Mediated Changes to the Epithelial Cell Proteome: 2-D Gel Analysis"],"prefix":"10.1371","volume":"8","author":[{"given":"Caroline","family":"Schrodt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Gawinowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert L.","family":"DuPont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,7,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1708-8305.2006.00084.x","article-title":"Rifaximin treatment of pathogen-negative travelers\u2019 diarrhea","volume":"14","author":"HL DuPont","year":"2007","journal-title":"Journal of travel medicine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1469-0691.2004.00997.x","article-title":"Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci","volume":"10","author":"HL DuPont","year":"2004","journal-title":"Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1542-3565(03)00322-7","article-title":"Enteroaggregative <italic>Escherichia coli<\/italic> diarrhea in travelers: response to rifaximin therapy","volume":"2","author":"RM Infante","year":"2004","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10620-006-9442-4","article-title":"Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy","volume":"52","author":"CB Leevy","year":"2007","journal-title":"Digestive diseases and sciences"},{"key":"ref5","first-page":"53","article-title":"Cyclic treatment of chronic hepatic encephalopathy with rifaximin. Results of a double-blind clinical study","volume":"49","author":"C Loguercio","year":"2003","journal-title":"Minerva gastroenterologica e dietologica"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1572-0241.2003.07283.x","article-title":"Therapy of travelers\u2019 diarrhea with rifaximin on various continents","volume":"98","author":"R Steffen","year":"2003","journal-title":"The American journal of gastroenterology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1345\/aph.1K345","article-title":"Rifaximin treatment for symptoms of irritable bowel syndrome","volume":"42","author":"AL Fumi","year":"2008","journal-title":"The Annals of pharmacotherapy"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/14787210.3.2.201","article-title":"Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections","volume":"3","author":"L Gerard","year":"2005","journal-title":"Expert review of anti-infective therapy"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.3748\/wjg.v17.i42.4643","article-title":"Rifaximin in the treatment of inflammatory bowel disease","volume":"17","author":"M Guslandi","year":"2011","journal-title":"World journal of gastroenterology : WJG"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/ibd.20187","article-title":"Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study","volume":"13","author":"KL Isaacs","year":"2007","journal-title":"Inflammatory bowel diseases"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/CEG.S18051","article-title":"High-dose rifaximin treatment alleviates global symptoms of irritable bowel syndrome","volume":"4","author":"J Jolley","year":"2011","journal-title":"Clinical and experimental gastroenterology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/14656566.2011.546347","article-title":"Biologic properties and clinical uses of rifaximin","volume":"12","author":"HL DuPont","year":"2011","journal-title":"Expert opinion on pharmacotherapy"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/499950","article-title":"Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders","volume":"42","author":"JA Adachi","year":"2006","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/AAC.00691-09","article-title":"Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles","volume":"54","author":"EL Brown","year":"2010","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nprot.2009.143","article-title":"Expression, purification and use of recombinant annexin V for the detection of apoptotic cells","volume":"4","author":"SE Logue","year":"2009","journal-title":"Nature protocols"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1128\/IAI.72.10.5741-5749.2004","article-title":"Increased rate of apoptosis and diminished phagocytic ability of human neutrophils infected with Afa\/Dr diffusely adhering <italic>Escherichia coli<\/italic> strains","volume":"72","author":"P Brest","year":"2004","journal-title":"Infection and immunity"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1128\/IAI.00860-09","article-title":"The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells","volume":"77","author":"A Samba-Louaka","year":"2009","journal-title":"Infection and immunity"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/JB.00844-07","article-title":"Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli","volume":"190","author":"E Loukiadis","year":"2008","journal-title":"Journal of bacteriology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1046\/j.1365-2958.2003.03821.x","article-title":"Enteropathogenic and enterohaemorrhagic <italic>Escherichia coli<\/italic> deliver a novel effector called Cif, which blocks cell cycle G2\/M transition","volume":"50","author":"O Marches","year":"2003","journal-title":"Molecular microbiology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1472-765X.2007.02154.x","article-title":"Induction of apoptosis in Caco-2 and HT-29 human intestinal epithelial cells by enterohemolysin produced by classic enteropathogenic <italic>Escherichia coli<\/italic>","volume":"45","author":"PM Figueiredo","year":"2007","journal-title":"Letters in applied microbiology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1128\/IAI.66.8.3918-3924.1998","article-title":"Hemolysin-positive enteroaggregative and cell-detaching <italic>Escherichia coli<\/italic> strains cause oncosis of human monocyte-derived macrophages and apoptosis of murine J774 cells","volume":"66","author":"C Fernandez-Prada","year":"1998","journal-title":"Infection and immunity"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"G467","DOI":"10.1152\/ajpgi.00364.2009","article-title":"Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase","volume":"299","author":"KT Chen","year":"2010","journal-title":"American journal of physiology Gastrointestinal and liver physiology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1073\/pnas.0712140105","article-title":"Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition","volume":"105","author":"RF Goldberg","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.chom.2007.10.010","article-title":"Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota","volume":"2","author":"JM Bates","year":"2007","journal-title":"Cell host & microbe"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.gastro.2008.06.006","article-title":"A new role for intestinal alkaline phosphatase in gut barrier maintenance","volume":"135","author":"K Geddes","year":"2008","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1136\/gut.2010.211706","article-title":"Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota","volume":"59","author":"MS Malo","year":"2010","journal-title":"Gut"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/gut.2007.128868","article-title":"Role of alkaline phosphatase in colitis in man and rats","volume":"58","author":"A Tuin","year":"2009","journal-title":"Gut"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1111\/j.1742-4658.2008.06659.x","article-title":"Antimicrobial effects of H4-(86\u2013100), histogranin and related compounds-possible involvement of DNA gyrase","volume":"275","author":"S Lemaire","year":"2008","journal-title":"The FEBS journal"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1006\/bbrc.2001.5020","article-title":"Histone H1: an antimicrobial protein of Atlantic salmon (Salmo salar)","volume":"284","author":"RC Richards","year":"2001","journal-title":"Biochemical and biophysical research communications"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1128\/IAI.66.7.3255-3263.1998","article-title":"Potential role of epithelial cell-derived histone H1 proteins in innate antimicrobial defense in the human gastrointestinal tract","volume":"66","author":"FR Rose","year":"1998","journal-title":"Infection and immunity"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/bj20020980","article-title":"Anti-microbial properties of histone H2A from skin secretions of rainbow trout, <italic>Oncorhynchus mykiss<\/italic>","volume":"368","author":"JM Fernandes","year":"2002","journal-title":"The Biochemical journal"},{"key":"ref32","first-page":"3268","article-title":"Pepsin-mediated processing of the cytoplasmic histone H2A to strong antimicrobial peptide buforin I. Journal of immunology","volume":"165","author":"HS Kim","year":"2000"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/psc.851","article-title":"Isolation and characterization of antimicrobial proteins and peptide from chicken liver","volume":"13","author":"GH Li","year":"2007","journal-title":"Journal of peptide science: an official publication of the European Peptide Society"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.108.6.925","article-title":"Bactericidal action of histone","volume":"108","author":"JG Hirsch","year":"1958","journal-title":"The Journal of experimental medicine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/PL00000838","article-title":"WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases","volume":"58","author":"D Li","year":"2001","journal-title":"Cellular and molecular life sciences: CMLS"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"10317","DOI":"10.1158\/0008-5472.CAN-06-3313","article-title":"RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase","volume":"67","author":"A Scuto","year":"2007","journal-title":"Cancer research"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"9797","DOI":"10.1074\/jbc.275.13.9797","article-title":"RbAp48 belongs to the histone deacetylase complex that associates with the retinoblastoma protein","volume":"275","author":"E Nicolas","year":"2000","journal-title":"The Journal of biological chemistry"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-230X-11-14","article-title":"The actin-bundling protein fascin is overexpressed in inflammatory bowel disease and may be important in tissue repair","volume":"11","author":"D Qualtrough","year":"2011","journal-title":"BMC gastroenterology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.lfs.2010.02.010","article-title":"Overexpression of a 60-kDa heat shock protein enhances cytoprotective function of small intestinal epithelial cells","volume":"86","author":"M Takada","year":"2010","journal-title":"Life sciences"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/bbrc.2001.5427","article-title":"Heat shock proteins: endogenous modulators of apoptotic cell death","volume":"286","author":"C Garrido","year":"2001","journal-title":"Biochemical and biophysical research communications"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/35019501","article-title":"Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome","volume":"2","author":"HM Beere","year":"2000","journal-title":"Nature cell biology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1093\/emboj\/19.16.4310","article-title":"Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90","volume":"19","author":"P Pandey","year":"2000","journal-title":"The EMBO journal"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/35019510","article-title":"Negative regulation of the Apaf-1 apoptosome by Hsp70","volume":"2","author":"A Saleh","year":"2000","journal-title":"Nature cell biology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1074\/jbc.275.14.10519","article-title":"Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation","volume":"275","author":"J Lewis","year":"2000","journal-title":"The Journal of biological chemistry"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"10832","DOI":"10.1073\/pnas.170276797","article-title":"Modulation of Akt kinase activity by binding to Hsp90","volume":"97","author":"S Sato","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.4049\/jimmunol.173.10.6319","article-title":"Pathogen-induced apoptotic neutrophils express heat shock proteins and elicit activation of human macrophages","volume":"173","author":"L Zheng","year":"2004","journal-title":"Journal of immunology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0068550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T21:50:39Z","timestamp":1596232239000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0068550"}},"subtitle":[],"editor":[{"given":"Hendrik W.","family":"van Veen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,26]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0068550","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,26]]}}}